(19)
(11) EP 3 700 936 A1

(12)

(43) Date of publication:
02.09.2020 Bulletin 2020/36

(21) Application number: 17929557.1

(22) Date of filing: 24.10.2017
(51) International Patent Classification (IPC): 
C07K 16/30(2006.01)
G01N 33/574(2006.01)
(86) International application number:
PCT/US2017/058036
(87) International publication number:
WO 2019/083506 (02.05.2019 Gazette 2019/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(71) Applicant: Go Therapeutics, Inc.
Cambridge, Massachusetts 02142 (US)

(72) Inventor:
  • WHITE, Thayer
    Boxford, Massachusetts 01920 (US)

(74) Representative: Wilding, James Roger et al
Mathys & Squire LLP The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) ANTI-GLYCO-MUC1 ANTIBODIES AND THEIR USES